Results 11 to 20 of about 908,413 (222)
Baylor University Medical Center Proceedings, 2019 Acquired inhibitors of coagulation are a group of rare but potentially life-threatening blood disorders characterized by the presence of autoantibodies directed against clotting factor. Autoantibody against factor VIII is the most common form of clotting factor inhibitor, a condition also known as acquired hemophilia A.
Yadav, Pandey +4 more
core +8 more sources
Turkish Journal of Hematology, 2014 Acquired hemophilia is a rare coagulation, due to the presence of autoantibodies directed against acquired factor VIII. It remains idiopathic in almost half the cases, as in other cases, various etiologies are responsible, including some autoimmune diseases.
Şinasi Özsoylu
doaj +6 more sources
Diagnosis and Treatment of Acquired Hemophilia A (AHA) with Bullous Pemphigoid [PDF]
Jurnal Penyakit Dalam Indonesia, 2016 Acquired hemophilia A is a condition in which coagulation factor VIII become inactive due to autoantibody formation. This condition is related to pregnancy, malignancy, and autoimmune disease with skin disorder. In this case report, a 66 years woman with
Rasco Sandy Sihombing +7 more
doaj +2 more sources
Deferral of immunosuppression in acquired hemophilia [PDF]
Blood AdvancesJerome Teitel, Jean St-Louis
doaj +5 more sources
, 2011 Acquired hemophilia A is a rare but often life-threatening hemorrhagic disorder characterized by an autoantibody directed against coagulation factor VIII. Fifty per cent of cases are idiopathic whereas the remaining 50% are associated with pregnancy, autoimmune conditions, malignancies and drugs.
Franchini M, LIPPI, Giuseppe
openaire +3 more sources
New Developments in Diagnosis and Management of Acquired Hemophilia and Acquired von Willebrand Syndrome [PDF]
HemaSphere, 2021 Acquired hemophilia A and acquired von Willebrand syndrome are rare, but life-threatening bleeding disorders that require prompt diagnosis and treatment by hematologists.
Frank W. G. Leebeek
doaj +2 more sources
Journal of Blood Medicine, 2012 Shinsaku Imashuku,1 Naoko Kudo,1 Kagekatsu Kubo,1 Katsuyasu Saigo,1 Nanako Okuno,2 Kaoru Tohyama21Division of Hematology, Takasago-seibu Hospital, Takasago, Japan; 2Department of Laboratory Medicine, Kawasaki Medical School, Kurashiki, JapanBackground ...
Okuno N +5 more
doaj +1 more source
Acquired hemophilia A: emerging treatment options
Journal of Blood Medicine, 2015 Maissaa Janbain,1 Cindy A Leissinger,1 Rebecca Kruse-Jarres2 1Louisiana Center for Bleeding and Clotting Disorders, Tulane University Medical Center, New Orleans, LA, USA; 2Washington Center for Bleeding Disorders, Blood Works NW, Seattle, WA, USA ...
Janbain M, Leissinger CA, Kruse-Jarres R
doaj +1 more source
The management of hemophilia in elderly patients
Clinical Interventions in Aging, 2007 Massimo Franchini1, Annarita Tagliaferri2, Pier Mannuccio Mannucci31Transfusion and Hemophilia Center, City Hospital of Verona, Italy; 2Regional Reference Center for Inherited Bleeding Disorders, University Hospital of Parma, Italy; 3Angelo Bianchi ...
Massimo Franchini +2 more
doaj +1 more source
Gaceta Médica de México, 2023 Acquired hemophilia (AH) is an autoimmune hemostatic disorder mediated by autoantibodies directed against factor VIII: C. In 52% of cases, the cause is unknown or is not associated with other pathological entities; in the rest, there are concomitant factors: lupus, rheumatoid arthritis, cancer, pregnancy, and medications.
Jaime, García-Chávez +1 more
openaire +2 more sources